Assad J. Kazeminy - 13 Feb 2023 Form 4 Insider Report for Lucy Scientific Discovery, Inc.

Role
Chief Scientific Officer
Signature
/s/ Christopher McElvany, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
13 Feb 2023
Net transactions value
+$204,000
Form type
4
Filing time
15 Feb 2023, 19:56:34 UTC
Previous filing
09 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSDI Common Shares Other $204,000 +85,000 $2.40 85,000 13 Feb 2023 ALK Biopharmaceutical LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These common shares were issued AJK Biopharmaceutical LLC ("AJK") pursuant to a debt settlement with the Issuer in satisfaction of approximately $204,000 due to AJK in consulting fees.
F2 The securities are held by AJK Biopharmaceutical LLC ("AJK"). The reporting person is the sole member of AJK. The reporting persons disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.